跳到正文
原文
STAT· @statnews · X·· 2026-10-11AI 评分22
AI 导读

研究显示,美国品牌药的平均支付价格是其他富裕国家的三到四倍。 但专家坚称,一个临界点即将到来,这将使政府干预遏制医疗成本变得不可避免。https://bit.ly/4edjsFi

正文

Research shows that the U.S. pays, on average, anywhere from three to four times as much for brand-name drugs compared with other wealthy countries.

But a breaking point is imminent, one that makes government intervention to curb health care costs inevitable, experts insist. https://bit.ly/4edjsFi

来源:STAT · x.com